Podocalyxin is a marker of poor prognosis in colorectal cancer
Podocalyxin is a marker of poor prognosis in colorectal cancer
Over two decades ago, a proposal was that two different colorectal cancer (CRC) entities existed, based on tumour location either proximal (right) or distal (left) of the splenic flexure. Proximal and distal tumours exhibit different clinical, epidemiological, and biological characteristics